Derivatives: Anticipated adjustment in Karo Bio due to rights issue (22/09)


The following information is based on a press release from Karo Bio AB (Karo
Bio) published on October 26, 2009 and may be subject to change. 

The board of Karo Bio has proposed that the Extra General Meeting (EGM), on
November 10, 2009, approves a rights issue (1:3), whereby shareholders are
entitled to one (1) new share for every three (3) shares held. The subscription
price is set at SEK 4.30. The scheduled Ex-date is November 13, 2009. Provided
that the EGM approves the proposed rights issue, NASDAQ OMX Derivatives Markets
will carry out a re-calculation of options and forwards in Karo Bio. 

For further information, please see the attached file.

Attachments

22_karo bio_rights_issue_1.pdf